[1] Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications [J].En? docr Rev, 2004,25(4):543-567. [/br][2] Aragno M, Mastrocola R, Alloatti G ,et al. Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats [J].Endo? crinology,2008,149(1):380-388. [/br][3] Porter KE, Turner NA. Cardiac fibmblasts: at the heart of myocardial remodeling [J]. Pharmacol Ther,2009,123(2): 255-278. [/br][4] Khan R, Sheppard R. Fibrosis in heart disease: understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia [J]. Immunology,2006,118 (1): 10-24. [/br][5] Sun Y, Zhang J, Zhang JQ, et al . Local angiotensin Ⅱ and transforming growth factor β1 in renal fibrosis of rats [J]. Hy? pertension,2000,35(5) :1078-1084. [/br][6] Adam O,Lavall D,Theobald K, et al.Rac1- induced connec? tive tissue growth factor regulates connexin 43 and N- cadherin expression in atrial fibrillation [J].J Am Coll Cardiol, 2010, 55(5) : 469-480. [/br][7] Adam O, Theobald K, Lavall D,et al. Increased lysyl oxidase expression and collagen cross- linking during atrial fibrillation [J].J Mol Cell Cardiol, 2011,50(4) : 678-685. [/br][8] Chen MM, Lam A, Abraham JA, et al. CTGF expression is induced by TGF- beta in cardiac f ibroblasts and cardiac myo? cytes: a potential role in heart fibrosis [J]. Mol Cell Cardiol, 2000(32): 1805 -1819. [/br][9] 胡爽,于俊民,张小波,等.血管紧张素Ⅱ受体拮抗剂抑制心肌纤 维化的研究进展[J].临床心血管病杂志,2014,30(12):1022- 1024.